Listing 1 - 10 of 48 | << page >> |
Sort by
|
Choose an application
Hodgkin Disease. --- Hodgkin's disease --- Hodgkin disease --- Hodgkin lymphoma --- Hodgkin's lymphoma --- Lymphadenoma --- Lymphogranuloma --- Lymphogranulomatosis --- Lymphosarcoma --- Pseudoleucemia --- Lymphomas --- Granuloma, Hodgkin's --- Granuloma, Hodgkins --- Hodgkin Lymphoma, Adult --- Hodgkin's Disease --- Hodgkin's Lymphoma --- Hodgkins Disease --- Lymphocyte Depletion Hodgkin's Lymphoma --- Lymphocyte-Rich Classical Hodgkin's Lymphoma --- Mixed Cellularity Hodgkin's Lymphoma --- Nodular Lymphocyte-Predominant Hodgkin's Lymphoma --- Nodular Sclerosing Hodgkin's Lymphoma --- Granuloma, Hodgkin --- Granuloma, Malignant --- Hodgkin Lymphoma --- Lymphogranuloma, Malignant --- Adult Hodgkin Lymphoma --- Disease, Hodgkin --- Disease, Hodgkin's --- Disease, Hodgkins --- Hodgkin Granuloma --- Hodgkin's Granuloma --- Hodgkins Granuloma --- Hodgkins Lymphoma --- Lymphocyte Rich Classical Hodgkin's Lymphoma --- Lymphogranulomas, Malignant --- Lymphoma, Hodgkin --- Lymphoma, Hodgkin's --- Malignant Granuloma --- Malignant Granulomas --- Malignant Lymphogranuloma --- Malignant Lymphogranulomas --- Nodular Lymphocyte Predominant Hodgkin's Lymphoma --- Reed-Sternberg Cells --- Hodgkin's disease. --- Hodgkin Disease
Choose an application
Fast Facts: Lymphoma is a valuable handbook for training doctors and specialist nurses working in the field of hemato-oncology, and will be of interest to the inquiring patient or carer who wishes to know more about lymphoma.
Lymphomas. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors
Choose an application
The peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified, accurate diagnosis remains challenging, requiring careful, expert integration of the clinical and pathological findings. The treatment of PTCL is also challenging. Protocols for the different subtypes are only just beginning to emerge, hindered by the complexities of conducting trials in such uncommon and varied conditions. While first-line treatment with conventional chemotherapy is seldom curative, patients who achieve remission may be eligible for stem cell transplantation, offering the possibility of long-term disease control if not cure. Targeted biologics are also being developed as unique cytotoxic markers are identified. 'Fast Facts: Peripheral T-Cell Lymphomas' is a new title in the Fast Facts extensive hemato-oncology library, written by experts in this emerging field. This handbook will be useful to anyone involved in the care of patients with PTCL, including haematologists, oncologists, specialist nurses and primary care providers, raising awareness of these rare lymphomas and the current – and emerging – approaches to diagnosis and treatment.
Lymphomas --- Diagnosis. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors
Choose an application
Hodgkin's Lymphoma is the book consisting of 11 chapters: Recent insights into the biology of Hodgkin's lymphoma, including historical aspects, epidemiology, pathophysiology, genetic defects, and prognostic indicators are explained in the intro chapters. After a translational chapter from tumor microenvironment to immunotherapeutic approach, treatment of early stage, advanced, and refractory Hodgkin's lymphoma are explained in the following chapters. MALT lymphoma and adverse effects of chemotherapy and radiotherapy in the affected patients are discussed in the subsequent chapters, while the final chapter is focused on survivorship in Hodgkin's lymphoma. The book is intended to present recent advances in the pathophysiology of Hodgkin's lymphoma as well as practical approach to diagnosis and management in clinical practice, which is hoped to be welcomed by the physicians, who wish to learn more about Hodgkin's lymphoma.
Oncology. --- Hodgkin's disease. --- Hodgkin disease --- Hodgkin lymphoma --- Hodgkin's lymphoma --- Lymphadenoma --- Lymphogranuloma --- Lymphogranulomatosis --- Lymphosarcoma --- Pseudoleucemia --- Lymphomas --- Tumors --- Oncology
Choose an application
Lymphoma affects all ages. Advances in diagnostic cellular and molecular techniques coupled with new treatment options are improving patient outcomes. This third edition of our bestselling 'Fast Facts: Lymphoma' distills the most important aspects of diagnosis and management into an up-to-date and highly accessible well-illustrated overview that includes: • a clear outline of the nature of lymphoma • the essentials of clinical presentation, biopsy and histology • a synopsis of current laboratory diagnostics, including immunophenotyping, cytogenetics and microarray technology, and updated to include the latest molecular genetic techniques • key aspects of staging and initial therapy • clearly illustrated overviews of the pathology, presentation, treatment and prognosis of each lymphoma subtype • new treatment options, including targeted biological therapies and chimeric antigen receptor T cells (CAR T cells) • a practical overview of supportive care for the complications of lymphoma. Written by three lymphoma experts from the UK and USA, 'Fast Facts: Lymphoma' gives an interesting international perspective to this challenging disease. Its clarity and colorful format make it a valuable resource for senior health professionals seeking an accessible update in this area of hemato-oncology, trainee doctors and specialist nurses who are new to it, and individuals affected by lymphoma and seeking more information. Contents: • Epidemiology • Cellular and molecular aspects • Presentation, biopsy and diagnostic laboratory techniques • Staging and general management principles • Aggressive B-cell lymphomas • Indolent B-cell lymphomas • T-cell and natural-killer cell lymphomas • Immunocompromised and HIV-positive patients • Hodgkin lymphoma • Treatment modalities • Supportive care
Lymphomas. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors
Choose an application
Dans les années 1980, le traitement des lymphomes reposait sur la chimiothérapie de type CHOP pour les lymphomes non hodgkiniens (LNH) et de type MOPP pour les lymphomes de hodgkin (LH). La première ne permettait pas plus de 30 % de guérison pour les LNH et si la seconde thérapie s'accompagnait de 60 à 70 % de guérison pour les LH, elle entraînait des risques d'infertilité et de second cancer avec au premier plan le risque de leucémies aiguës myéloïdes.Les thérapeutiques ont considérablement évolué depuis cette époque. Dans les lymphomes non hodgkiniens, la distinction entre les lymphomes B et
Lymphomas. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors
Choose an application
Lymphomas. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors
Choose an application
This book describes unusual cases of cutaneous lymphomas and is of special interest for clinicians and pathologists dealing with the vexing subject of cutaneous lymphoma. In addition to the case description, it gives the clinical, histological, and in most cases also the phenotypical features and the results of molecular techniques. A commentary puts the observations into the context of cutaneous lymphomas. Related papers are cited. The book will be especially helpful in cases which do not fit into the normal spectrum of cutaneous lymphomas. Rare entities of cutaneous lymphomas are demonstrated with high-quality pictures (4-color) and a concise text in an appealing format throughout the book. The new WHO/EORTC-Classification of Cutaneous lymphomas includes more than 30 entities of Cutaneous T-cell and Cutaneous B-cell lymphomas.
Lymphomas. --- Skin --- Tumors. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors --- Dermatology. --- Oncology . --- Oncology. --- Medicine --- Diseases
Choose an application
This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
Lymphomas --- Treatment. --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors --- Oncology . --- Hematology. --- Oncology. --- Haematology --- Internal medicine --- Blood --- Diseases
Choose an application
This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Hematology. --- Oncology . --- Oncology. --- Tumors --- Haematology --- Internal medicine --- Blood --- Diseases --- Hodgkin's disease. --- Hodgkin disease --- Hodgkin lymphoma --- Hodgkin's lymphoma --- Lymphadenoma --- Lymphogranuloma --- Lymphogranulomatosis --- Lymphosarcoma --- Pseudoleucemia --- Lymphomas
Listing 1 - 10 of 48 | << page >> |
Sort by
|